APP - A Fresenius Kabi CompanyLogo
  • Home
  • Contact Us
  • Order Information
  • Fresenius Kabi AG
  • About Us
    • Fact Sheets
    • History
    • Fresenius Kabi AG
      • Our Business Fields
      • Our Mission
      • Locations Worldwide
    • APP Executive Management
      • John Ducker
      • J. Frank Harmon
      • Steven J. Adams
      • Jack Silhavy
      • Christopher Bryant, PhD
      • Scott W. Meacham
      • Brent Eck
      • Surendera Tyagi, PhD
      • James W. Callanan
    • APP Corporate Governance
      • Audit Committee
      • Ethics and Compliance
      • Supplier Relations
    • APP Corporate Responsibility
      • Environmental, Health and Safety
        • Employee Safety
        • Strategic Involvement
        • Tactical Involvement
  • Our Products
    • Alphabetical
    • Brand-to-Generic
    • Latex Information
    • New Products
    • Preservative Free
    • TALLman Labeling
    • Product Updates
    • Therapeutic Class
    • Wholesale Item Numbers
    • New Product Alerts
  • Product Sites
    • Heparin
    • Diprivan
    • Naropin
  • Patient Safety
    • Health Care Professionals
      • Heparin Supply Chain Integrity
      • Stabilizing the Heparin Marketplace
      • Working Together for Patient Safety
      • Preventing Medical Errors
        • Labeling
        • Bar Coding
        • Anticoagulation Management Program
        • Prescription Writing Do's and Don'ts
        • Common Mistakes
        • IHI Recommendations
      • USP Standards for Unfractionated Heparin
        • FAQs - APP UFH Products
        • FAQs - Clinical Considerations
        • New Vial Label
    • Patients
      • What is Heparin?
      • Heparin Supply Chain Integrity
      • Stabilizing the Heparin Marketplace
  • News and Media
    • Fact Sheets
    • SEC Filings
    • Press Releases
    • Other News
    • CVRs
    • Cost Basis for Separation
    • Contact
    • RSS Feeds
  • Careers
    • Job Openings
    • How to Apply
    • Equal Opportunity Employer
    • Benefits
jtemplate.ru - free extensions for joomla
  • Home
  • Our Products

Our Products

  • Alphabetical
  • Brand-to-Generic
  • Latex Information
  • New Products
  • Preservative Free
  • TALLman Labeling
  • Product Updates
  • Therapeutic Class
  • Wholesale Item Numbers
  • New Product Alerts

Product Updates

  • Communications for Healthcare Professionals
    • Ifosfamide Injection - July 15, 2011
    • Vancomycin Hydrochloride for Injection, USP - June 29, 2011
    • Propofol Injectable Emulsion, USP - May 19, 2011
    • Cytarabine Injection - April 15, 2011
    • Irinotecan Hydrochloride Injection - March 22, 2011
    • Cytarabine Injection - March 15, 2011
    • Kanamycin Injection, USP - March 15, 2011
    • Local or Regional Anesthetics (Caines) - July 15, 2010
    • Propofol Injectable Emulsion, USP - June 9, 2010
    • Diprivan® (propofol) Supply Update - October 29, 2009
    • Diprivan® (propofol) - July, 2009
  • Fresenius Propoven 1% (propofol 1%) Reference Info - March 9, 2010
    • APP Introduces Propoven 20mL Glass Ampule - March 31, 2010
    • Fresenius Propoven 1% (propofol 1%) - March 9, 2010
    • APP Resuming Importation of Fresenius Propoven 1% (propofol 1%) - March 9, 2010
    • Fresenius Propoven 1% (propofol 1%) Package Insert
    • Propoven MSDS FK Sweden
    • Propoven MSDS FK Austria
Print Page Print this page
All Rights Reserved, APP © May 2012 |
  • Site Map
  • Imprint
  • Legal Disclaimer
APP - Registered Trademark